Smith Group Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.95M | Buy |
2,117
+330
| +18% | +$335K | 0.1% | 61 |
|
|
2025
Q4 | $1.92M | Buy |
1,787
+198
| +12% | +$189K | 0.1% | 64 |
|
|
2025
Q3 | $1.21M | Sell |
1,589
-5
| -0.3% | -$3.72K | 0.07% | 80 |
|
|
2025
Q2 | $1.24M | Sell |
1,594
-20
| -1% | -$15.5K | 0.08% | 81 |
|
|
2025
Q1 | $1.33M | Sell |
1,614
-535
| -25% | -$445K | 0.1% | 73 |
|
|
2024
Q4 | $1.66M | Sell |
2,149
-40
| -2% | -$33.1K | 0.12% | 72 |
|
|
2024
Q3 | $1.94M | Buy |
2,189
+696
| +47% | +$626K | 0.16% | 49 |
|
|
2024
Q2 | $1.35M | Sell |
1,493
-7,926
| -84% | -$6.34M | 0.12% | 50 |
|
|
2024
Q1 | $7.33M | Sell |
9,419
-3,330
| -26% | -$2.37M | 0.42% | 64 |
|
|
2023
Q4 | $7.43M | Buy |
+12,749
| New | +$7.44M | 0.43% | 72 |
|
|
2022
Q1 | $21K | Hold |
75
| – | – | ﹤0.01% | 234 |
|
|
2021
Q4 | $21K | Hold |
75
| – | – | ﹤0.01% | 248 |
|
|
2021
Q3 | $17K | Hold |
75
| – | – | ﹤0.01% | 258 |
|
|
2021
Q2 | $17K | Sell |
75
-160,788
| -100% | -$32.3M | ﹤0.01% | 252 |
|
|
2021
Q1 | $30M | Sell |
160,863
-75,200
| -32% | -$14.7M | 1.59% | 21 |
|
|
2020
Q4 | $39.9M | Sell |
236,063
-56,669
| -19% | -$8.46M | 2.31% | 11 |
|
|
2020
Q3 | $43.3M | Sell |
292,732
-11,530
| -4% | -$1.78M | 2.26% | 10 |
|
|
2020
Q2 | $50M | Sell |
304,262
-70,525
| -19% | -$10.8M | 2.75% | 8 |
|
|
2020
Q1 | $52M | Buy |
374,787
+98,551
| +36% | +$13.5M | 2.84% | 5 |
|
|
2019
Q4 | $36.3M | Buy |
276,236
+31,112
| +13% | +$3.61M | 1.52% | 17 |
|
|
2019
Q3 | $27.4M | Sell |
245,124
-6,790
| -3% | -$756K | 0.96% | 34 |
|
|
2019
Q2 | $27.9M | Sell |
251,914
-110,195
| -30% | -$13M | 0.94% | 37 |
|
|
2019
Q1 | $47M | Sell |
362,109
-309,172
| -46% | -$37.6M | 1.52% | 19 |
|
|
2018
Q4 | $77.7M | Sell |
671,281
-37,284
| -5% | -$4.16M | 2.74% | 4 |
|
|
2018
Q3 | $76.1M | Sell |
708,565
-57,783
| -8% | -$5.78M | 2.16% | 11 |
|
|
2018
Q2 | $65.4M | Buy |
+766,348
| New | +$62.9M | 1.89% | 12 |
|
|
2016
Q1 | – | Sell |
-26
| Closed | -$2K | – | 498 |
|
|
2015
Q4 | $2K | Hold |
26
| – | – | ﹤0.01% | 460 |
|
|
2015
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 395 |
|
|
2015
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 385 |
|
|
2015
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 396 |
|
|
2014
Q4 | $2K | Hold |
26
| – | – | ﹤0.01% | 400 |
|
|
2014
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 379 |
|
|
2014
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 389 |
|
|
2014
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 382 |
|
|
2013
Q4 | $1K | Sell |
26
-3
| -10% | -$150 | ﹤0.01% | 381 |
|
|
2013
Q3 | $1K | Sell |
29
-139,971
| -100% | -$7.33M | ﹤0.01% | 402 |
|
|
2013
Q2 | $6.88M | Buy |
+140,000
| New | +$7.62M | 0.3% | 87 |
|
Other funds holding LLY
VCM
VPM
Smith Group Asset Management's LLY Position: Q1 2026 in Review
Smith Group Asset Management increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $335K and bringing the position to 2,117 shares worth $1.95M. The position accounts for 0.1% of the portfolio, ranked #61.
Smith Group Asset Management first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. The position peaked at $77.7M in Q4 2018. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Smith Group Asset Management held 2,117 shares of Eli Lilly worth $1.95M as of Q1 2026.
- Smith Group Asset Management bought 330 Eli Lilly shares in Q1 2026, an estimated $335K.
- Eli Lilly made up 0.1% of Smith Group Asset Management's portfolio in Q1 2026, its #61 holding.
- Smith Group Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
- Smith Group Asset Management's Eli Lilly position peaked at $77.7M in Q4 2018.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.